Stockreport

FDA OKs Aclaris' Eskata for seborrheic keratoses [Seeking Alpha]

Aclaris Therapeutics, Inc.  (ACRS) 
Last aclaris therapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: aclaristx.com
PDF FDA OKs Aclaris' Eskata for seborrheic keratosesThe FDAapproves Aclaris Therapeutics' (NASDAQ:ACRS) ESKATA (hydrogen peroxide) topical solution, 40% for the treatment of [Read more]